For a healthy adult aged 18–65 years without vitamin C deficiency, what is the recommended daily intake, does supplementation provide meaningful benefit for scurvy prevention, common cold, hypertension, cardiovascular disease, cancer, cataracts, skin aging, or iron absorption, and what are the safety limits and potential risks of high‑dose vitamin C?

Vitamin C Supplementation: Evidence-Based Recommendations for Healthy Adults

For healthy adults without vitamin C deficiency, routine supplementation beyond dietary intake provides no proven benefit for mortality, cardiovascular disease, cancer prevention, or quality of life, and the recommended daily intake of 75–110 mg is readily achievable through diet alone. 1, 2

Recommended Daily Intake

The evidence-based target varies by regulatory authority, reflecting different health perspectives:

• United States/Canada: 90 mg/day for men, 75 mg/day for women 2, 3
• European Union: 110 mg/day for men, 95 mg/day for women 3
• Minimum to prevent scurvy: 40–45 mg/day 1, 3, 4
• Optimal intake for tissue saturation: Approximately 200 mg/day achieves near-complete plasma saturation (≈70 µmol/L) and maximizes potential antioxidant benefits 2, 5

The five-fold variation in global recommendations (40–220 mg/day) stems from differing criteria: preventing scurvy versus achieving tissue saturation versus attempting chronic disease risk reduction. 1

Scurvy Prevention

• A minimum of 40–45 mg/day prevents scurvy in most individuals, with clinical deficiency developing within 8–12 weeks when intake falls below this threshold 3, 4
• This amount does not achieve tissue adequacy or optimal antioxidant protection 3
• Scurvy presents with petechiae, gingival bleeding, perifollicular hemorrhages, corkscrew hairs, and impaired wound healing 4
• Treatment requires 100 mg three times daily (300–500 mg/day total) for at least one month when symptomatic deficiency is present 4

Common Cold

The U.S. Preventive Services Task Force found insufficient evidence to recommend vitamin C supplementation for common cold prevention or treatment in the general population. 1 While some observational data suggest associations between higher vitamin C intake and reduced cold incidence, randomized controlled trials have not consistently demonstrated meaningful clinical benefit for mortality, morbidity, or quality of life outcomes. 6

Hypertension and Cardiovascular Disease

• A meta-analysis demonstrated significant reductions in systolic and diastolic blood pressure with a median intake of 500 mg/day (moderate-quality evidence) 2
• However, the USPSTF concluded that evidence is insufficient to recommend vitamin C supplementation for cardiovascular disease prevention, as randomized trials have not shown impact on mortality or major cardiovascular events 1
• Observational studies showing lower cardiovascular risk with high vitamin C intake may simply reflect healthier overall dietary patterns rather than vitamin C itself 6, 7

Cancer Prevention

The USPSTF explicitly states that evidence is insufficient to recommend for or against vitamin C supplementation for cancer prevention. 1 Available randomized trials are inadequate or conflicting, and confounding variables in observational studies cannot be determined. 1

Other Conditions

• Cataracts, skin aging: No high-quality evidence supports supplementation for these outcomes 1
• Iron absorption: Vitamin C enhances non-heme iron absorption when consumed with plant-based iron sources, but this is readily achieved through dietary vitamin C at meals 1

Safety Limits and Risks

Tolerable Upper Intake Level

• The established upper limit is 2,000 mg/day for adults, based on gastrointestinal upset (diarrhea) as the primary adverse effect 2, 3, 7
• Doses of 1,000 mg/day are well within the safety margin but provide no documented benefit beyond 200 mg/day for healthy adults 2

Critical Contraindications

Vitamin C supplementation is contraindicated in patients with:

• Hemochromatosis or iron overload conditions (can accelerate iron mobilization and cause fatal cardiac complications) 3
• G6PD deficiency (risk of hemolysis) 4
• Active oxalate kidney stones (vitamin C is metabolized to oxalate) 4
• Severe renal dysfunction (risk of oxalate nephropathy) 4

Absorption Limitations

Intestinal absorption of vitamin C saturates at higher oral doses due to transporter saturation; consequently, plasma concentrations plateau at intakes of 200–400 mg/day with no further rise at 1,000 mg/day. 2, 3 This represents a key physiologic limitation that undermines the rationale for high-dose supplementation in healthy individuals.

Special Populations Requiring Higher Intake

• Smokers: Require an additional 35 mg/day above baseline due to increased oxidative stress 2
• Pregnant women: Need 85–110 mg/day (additional 10–20 mg/day) 3
• Lactating women: Need 95–150 mg/day (additional 20–60 mg/day) 3
• Obesity: May blunt response to supplementation and potentially increase requirements 2
• Post-bariatric surgery, chronic dialysis, critical illness: Require 200–500 mg/day indefinitely 4

Practical Algorithm for Clinical Decision-Making

Step 1: Assess dietary intake

• One medium orange provides 75–90 mg vitamin C 4
• Five servings of fruits and vegetables daily, including at least one high-vitamin C source (citrus, berries, peppers, broccoli), readily achieves 200 mg/day 2

Step 2: Identify high-risk populations

Screen for: smoking, pregnancy/lactation, obesity, malabsorption conditions, chronic dialysis, post-bariatric surgery 2, 3, 4

Step 3: Supplementation decision

• If dietary intake is adequate (≥200 mg/day from food): No supplementation needed 2
• If dietary intake is suboptimal but patient is otherwise healthy: Recommend dietary modification first; if unsuccessful, consider 75–110 mg/day supplement 2, 3
• If high-risk population: 200–500 mg/day supplementation 4

Step 4: Avoid common pitfalls

• Do not measure plasma vitamin C during acute illness or inflammation (CRP >10 mg/L), as levels will be falsely low and misleading 4
• Do not recommend doses exceeding 2,000 mg/day 2, 3
• Do not supplement patients with hemochromatosis, G6PD deficiency, active kidney stones, or severe renal dysfunction without specialist consultation 3, 4
• Emphasize that supplementation does not replace the need for a healthy diet rich in fruits and vegetables 1

Key Evidence Limitations

The failure of randomized controlled trials to demonstrate benefit from vitamin C supplementation may reflect the fact that most study populations were already adequately supplied through dietary sources, obscuring any incremental effect. 6 Additionally, many trials allowed placebo groups to continue background supplementation up to the RDA, further limiting the ability to detect differences. 2 Phase III randomized trials designed for pharmaceutical drugs are fundamentally ill-suited to assess the health benefits of essential nutrients. 5

Despite biological plausibility and consistent observational data linking higher vitamin C intake with reduced chronic disease risk, definitive evidence from high-quality randomized trials demonstrating that supplementation improves mortality, morbidity, or quality of life in healthy adults is lacking. 1, 6